AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 265: F504-F510, 1993;
0363-6127/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balakrishnan, V. S.
Right arrow Articles by Williams, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balakrishnan, V. S.
Right arrow Articles by Williams, J. D.

AJP - Renal Physiology, Vol 265, Issue 4 504-F510, Copyright © 1993 by American Physiological Society


ARTICLES

A potential role for endogenous adenosine in control of human glomerular and tubular function

V. S. Balakrishnan, G. A. Coles and J. D. Williams
Institute of Nephrology, University of Wales College of Medicine, Cardiff Royal Infirmary, United Kingdom.

Adenosine has profound effects on renal function in experimental animals, but little is known about its role in human subjects. The recent advent of specific adenosine agonists and antagonists suitable for human use, however, now makes it possible to evaluate the influence of this potent vasoactive compound in both normal and pathological states. In this study we assessed the effects of FK-453, a nonxanthine, selective adenosine A1-receptor antagonist, on normal renal hemodynamics, tubular function, and plasma renin release. Eight healthy, male subjects each received three single oral doses of FK-453 (50, 100, and 200 mg) in ascending dose order with random allocation of one matched placebo dose, each on a separate study day. Renal hemodynamics, tubular function, and plasma renin concentrations (PRC) were assessed at baseline and postdose on each study day. Glomerular filtration rate (clearance of 51Cr-labeled EDTA) rose by 18.0%, 3 h after the administration of 100 mg of FK-453 and by 18.3% and 23.5%, 2 and 3 h, respectively, after the 200-mg dose, which was significantly different from the changes following placebo. There were no significant changes in mean arterial blood pressure or effective renal plasma flow (clearance of 125I-Hippuran). In contrast there were statistically significant increases in urine flow rate and osmolar clearance, as well as absolute and fractional excretions of sodium, phosphate, bicarbonate, chloride, magnesium, and uric acid in response to FK-453. No glycosuria or aminoaciduria was detected on urinalysis. There was, in addition, a marked increase in PRC in response to FK-453.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Kulick, C. Panico, P. Gill, and W. J. Welch
Low salt intake increases adenosine type 1 receptor expression and function in the rat proximal tubule
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F37 - F41.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Castrop
Modulation of adenosine receptor expression in the proximal tubule: a novel adaptive mechanism to regulate renal salt and water metabolism
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F35 - F36.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
V. Vallon, B. Muhlbauer, and H. Osswald
Adenosine and kidney function.
Physiol Rev, July 1, 2006; 86(3): 901 - 940.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. B. Hansen and J. Schnermann
Vasoconstrictor and vasodilator effects of adenosine in the kidney
Am J Physiol Renal Physiol, October 1, 2003; 285(4): F590 - F599.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. K. Jackson and R. K. Dubey
Role of the extracellular cAMP-adenosine pathway in renal physiology
Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. S. WILCOX, W. J. WELCH, G. F. SCHREINER, and L. BELARDINELLI
Natriuretic and Diuretic Actions of a Highly Selective Adenosine A1 Receptor Antagonist
J. Am. Soc. Nephrol., April 1, 1999; 10(4): 714 - 720.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Gellai, G. F. Schreiner, R. R. Ruffolo Jr., T. Fletcher, R. DeWolf, and D. P. Brooks
CVT-124, a Novel Adenosine A1 Receptor Antagonist with Unique Diuretic Activity
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1191 - 1196.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. C. Pflueger, T. J. Berndt, and F. G. Knox
Effect of renal interstitial adenosine infusion on phosphate excretion in diabetes mellitus rats
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1998; 274(5): R1228 - R1235.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Srinivas, J. C. Shryock, D. M. Dennis, S. P. Baker, and L. Belardinelli
Differential A1 Adenosine Receptor Reserve for Two Actions of Adenosine on Guinea Pig Atrial Myocytes
Mol. Pharmacol., October 1, 1997; 52(4): 683 - 691.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online